68Ga-DOTATOC PET/CT after 1 cycle of PRRT with 90Y-DOTATOC visualizes changes in somatostatin receptor availability in neuroendocrine tumours

被引:0
|
作者
Van Binnebeek, S. [1 ]
Mottaghy, F. M. [2 ]
Koole, M. [1 ]
Baete, K. [1 ]
Vanbilloen, B. [1 ]
Terwinghe, C. [1 ]
Clement, P. [1 ]
Verbruggen, A. [1 ]
Mortelmans, L. [1 ]
Van Cutsem, E. [1 ]
Haustermans, K. [1 ]
Verslype, C. [1 ]
Deroose, C. M. [1 ]
机构
[1] UZ Leuven, Louvain, Belgium
[2] UK Aachen, Aachen, Germany
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S367 / S367
页数:1
相关论文
共 50 条
  • [41] Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours
    Buchmann, I.
    Henze, M.
    Engelbrecht, S.
    Eisenhut, M.
    Runz, A.
    Schaefer, M.
    Schilling, T.
    Haufe, S.
    Herrmann, T.
    Haberkorn, U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (10) : 1617 - 1626
  • [42] Detectability of PET/CT with 68Ga-DOTATOC for identifying suspected or unknown primary neuroendocrine tumors
    Nakamoto, Yuji
    Sano, Kohei
    Nakatani, Koya
    Arimoto, Maya
    Nobashi, Tomomi
    Togashi, Kaori
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [43] Serous cystadenoma mimicking cystic pancreatic neuroendocrine tumor on 68Ga-DOTATOC PET/CT
    Passand, Goudarz T.
    Marichez, Arthur
    Debordeaux, Eric
    Pinaquy, Jean-Baptiste
    Chiche, Laurence
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2022, 103 (11) : 563 - 565
  • [44] 68Ga-DOTATOC and 68Ga-PSMA PET/CT Unmasked a Case of Prostate Cancer With Neuroendocrine Differentiation
    Chen, Sirong
    Cheung, Shing Kee
    Wong, Ka-nin
    Wong, Kwok Kee
    Ho, Chi-lai
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (12) : 959 - 960
  • [45] Dynamic 68Ga-DOTATOC PET/CT and static image in NET patients Correlation of parameters during PRRT
    Van Binnebeek, Sofie
    Koole, Michel
    Terwinghe, Christelle
    Baete, Kristof
    Vanbilloen, Bert
    Haustermans, Karine
    Clement, Paul M.
    Bogaerts, Kris
    Verbruggen, Alfons
    Nackaerts, Kris
    Van Cutsem, Eric
    Verslype, Chris
    Mottaghy, Felix M.
    Deroose, Christophe M.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2016, 55 (03): : 104 - 114
  • [46] Risk stratification in pancreatic neuroendocrine tumours: the role of combined 68Ga-DOTATOC and 18F-FDG PET/CT
    Mapelli, Paola
    Partelli, Stefano
    Salgarello, Matteo
    Muffatti, Francesca
    Rancoita, Paola Maria
    Pasetto, Stefano
    Gianolli, Luigi
    Falconi, Massimo
    Picchio, Maria
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [47] Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours
    Nils F. Schreiter
    Winfried Brenner
    Munenobu Nogami
    Ralph Buchert
    Alexander Huppertz
    Ulrich-Frank Pape
    Vikas Prasad
    Bernd Hamm
    Martin H. Maurer
    European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 72 - 82
  • [48] 18F-FDG PET/CT and 68Ga-DOTATOC PET/CT in Diffuse Pancreatic Neuroendocrine Tumor
    Ji, Xia
    Dong, Aisheng
    He, Qi
    Dong, Hui
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (05) : E245 - E248
  • [49] Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours
    Schreiter, Nils F.
    Brenner, Winfried
    Nogami, Munenobu
    Buchert, Ralph
    Huppertz, Alexander
    Pape, Ulrich-Frank
    Prasad, Vikas
    Hamm, Bernd
    Maurer, Martin H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (01) : 72 - 82
  • [50] 68Ga-DOTATOC PET/CT as Tool for Diagnosis and Decision-Making Process of Neuroendocrine Tumors
    Peiro, I
    Vercher-Conejero, J. L.
    Suils-Ramon, J.
    Hernandez, L.
    Teule, A.
    Sanchez, C.
    Vilarrasa, N.
    Puig-de-la-Bellacasa, J.
    Guerrero, F.
    Villabona, C.
    NEUROENDOCRINOLOGY, 2020, 110 : 171 - 171